Evidence map›Paper›PMID 25425168›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2015

On comparing heterogeneity across biomarkers.

Robert J Steininger, Satwik Rajaram, Luc Girard, John D Minna, Lani F Wu, Steven J Altschuler

Abstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Biologically Relevant Heterogeneity: Metrics and Practical Insights.SLAS discovery : advancing life sciences R & D · 2017
    Review
  5. Morphological single cell profiling of the epithelial-mesenchymal transition.Integrative biology : quantitative biosciences from nano to macro · 2016
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robert J SteiningerGreen Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas.
Satwik RajaramDepartment of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, California.
Luc GirardHamon Center for Therapeutic Oncology Research and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
John D MinnaHamon Center for Therapeutic Oncology Research and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Lani F WuGreen Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas.
Steven J AltschulerGreen Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas.

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
Lung cancer heterogeneity and its impact on drug resistance.R01CA133253 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ALTSCHULER, STEVEN J · 2010 to 2015
$2.3M
Image based phenotypic profiling of single-cell responses to perturbationsR01GM081549 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI WU, LANI F · 2007 to 2011
$1.7M
Turnkey solution for image phenotype classificationR01GM085442 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ALTSCHULER, STEVEN J · 2008 to 2011
$1.2M
NCI NIH HHS P50 CA070907NCI NIH HHS P50CA70907NCI NIH HHS R01 CA133253NCI NIH HHS R01CA133253NIGMS NIH HHS R01 GM081549NIGMS NIH HHS R01 GM085442
6 · The paper itself

Abstract

Microscopy reveals complex patterns of cellular heterogeneity that can be biologically informative. However, a limitation of microscopy is that only a small number of biomarkers can typically be monitored simultaneously. Thus, a natural question is whether additional biomarkers provide a deeper characterization of the distribution of cellular states in a population. How much information about a cell's phenotypic state in one biomarker is gained by knowing its state in another biomarker? Here, we describe a framework for comparing phenotypic states across biomarkers. Our approach overcomes the current limitation of microscopy by not requiring costaining biomarkers on the same cells; instead, we require staining of biomarkers (possibly separately) on a common collection of phenotypically diverse cell lines. We evaluate our approach on two image datasets: 33 oncogenically diverse lung cancer cell lines stained with 7 biomarkers, and 49 less diverse subclones of one lung cancer cell line stained with 12 biomarkers. We first validate our method by comparing it to the "gold standard" of costaining. We then apply our approach to all pairs of biomarkers and use it to identify biomarkers that yield similar patterns of heterogeneity. The results presented in this work suggest that many biomarkers provide redundant information about heterogeneity. Thus, our approach provides a practical guide for selecting independently informative biomarkers and, more generally, will yield insights into both the connectivity of biological networks and the complexity of the state space of biological systems.

Indexed as

Biomarkers, TumorCarcinoma, Non-Small-Cell LungCell Line, TumorComputational BiologyFlow CytometryHumansImage Processing, Computer-AssistedLung NeoplasmsMicroscopySystems BiologyBiomarkers, Tumorbioimage informaticsbiological networksbiomarker selection; systems biologyheterogeneityinformation theorymicroscopysingle-cell variability

Identifiers

PMID25425168
PMCPMC4442742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.